scholarly journals PP122—Regulation of human leukocyte antigen expression and nevirapine-induced adverse drug reactions in a malawian hiv-positive population

2013 ◽  
Vol 35 (8) ◽  
pp. e53
Author(s):  
E.M. Cornejo Castro ◽  
D.F. Carr ◽  
V.A. Marshall ◽  
M. Chaponda ◽  
S. Lane ◽  
...  
Keyword(s):  
Human Leukocyte Antigen ◽  
Adverse Drug Reactions ◽  
Human Leukocyte ◽  
Antigen Expression ◽  
Hiv Positive ◽  
Drug Reactions ◽  
Leukocyte Antigen ◽  
Positive Population

scholarly journals Reducing severe cutaneous adverse and type B adverse drug reactions using pre‐stored human leukocyte antigen genotypes

2022 ◽  
Vol 12 (1) ◽  
Author(s):  
Kye Hwa Lee ◽  
Dong Yoon Kang ◽  
Hyun Hwa Kim ◽  
Yi Jun Kim ◽  
Hyo Jung Kim ◽  
...  
Keyword(s):  
Human Leukocyte Antigen ◽  
Adverse Drug Reactions ◽  
Human Leukocyte ◽  
Type B ◽  
Drug Reactions ◽  
Leukocyte Antigen

scholarly journals Pharmacogenomics Testing Confirmation of Carbamazepine Induced DRESS Reaction of an HLA-A*31:01 Positive, Polypharmacy Patient

2021 ◽  
Vol 12 (4) ◽  
pp. 20
Author(s):  
Leigh Speicher ◽  
Sheena Crosby ◽  
Michael J. Schuh
Keyword(s):  
Drug Reaction ◽  
Drug Interactions ◽  
Human Leukocyte Antigen ◽  
Adverse Drug Reactions ◽  
Human Leukocyte ◽  
Drug Reactions ◽  
Leukocyte Antigen ◽  
Medication Selection ◽  
Systemic Symptoms

Pharmacogenomics (PGx) melds well with polypharmacy as another tool to identify medication related problems (MRPs) more specifically so they may be solved most effectively. PGx can pre-emptively assist in medication selection, medication dosing or identify better medications for patients already taking a medication.  PGx can also confirm suspect medications of causing MRPs such as adverse drug reactions (ADRs) or drug interactions. In this case, PGx testing confirmed presence of a serious human leukocyte antigen (HLA) drug reaction with eosinophilia and systemic symptoms (DRESS) after a suspect medication had been stopped.

Sign in / Sign up

Export Citation Format

Share Document